Stocktoria

enVVeno Medical Corp NVNO

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
1/9
Piotroski F — financial health
-6.01
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Operating income-$20.9M-$23.8M-$25.2M-$24.9M-$16.9M
Net income-$19.5M-$21.8M-$23.5M-$24.7M-$16.5M
Operating cash flow-$15.6M-$16.8M-$18.9M-$15.6M-$11.8M
Free cash flow-$15.6M-$16.9M-$18.9M-$15.7M-$12.2M
Total assets$29.6M$45.0M$48.6M$41.7M$57.7M
Total liabilities$2.4M$2.8M$2.4M$2.9M$3.3M
Shareholders' equity$27.1M$42.2M$46.2M$38.7M$54.4M
Ratios
Return on assets-65.9%-48.5%-48.4%-59.2%-28.6%
Return on equity-71.8%-51.8%-50.9%-63.7%-30.4%
Current ratio13.5820.8834.2325.7834.84

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -6.01 (distress)

  • Working capital / assets 0.903
  • Retained earnings / assets -5.796
  • EBIT / assets -0.707
  • Equity / liabilities 11.155

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001661053 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.